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Abstract: Major hepatectomy (MH) is often considered the only
possible approach for colorectal liver metastasis (CRLM) at the
hepato-caval confluence (CC), but it is associated with high morbidity
and mortality. With the aim to reduce MH, we developed the ‘‘minor-
but-complex’’ (MbC) technique, which consists in the resection of less
than 3 adjacent liver segments with exposure of the CC and preservation
of hepatic outflow until spontaneous maturation of peripheral intrahe-
patic shunts between main hepatic veins. We have evaluated applica-
bility and outcome of MbC resections for the treatment of CRLM
involving the CC.
In this retrospective cohort study, all consecutive liver resections
(LR) performed for CRLM located in segments 1, 7, 8, or 4a were
classified as MINOR – removal of <3 adjacent segments; MbC –
removal of<3 adjacent segments with CC exposure; and MH – removal
of 3 adjacent segments. The rate of avoided MH was obtained by the
difference between the rate of potentially MH (PMH) plus potentially
inoperable cases and the rate of the MH performed. Taking into account
that postoperative mortality is mainly related to the amount of resected
liver, MbC was compared with minor resections for safety, complexity,
and outcome.
Of the 59 LR analyzed, 29 (49.1%) were deemed PMH and 4 (6.8%)
potentially inoperable. Eventually, MH was performed only in 8 (13.5%)
with a decrease rate of 42.4%. Minor LR was performed in 23 (39.0%) and
MbC LR in 28 (47.5%) patients. Among MbC cases, 32.1% had previous
liver treatments, 39.3% required vascular reconstruction (no reconstructed
vessel thrombosis occurred before maturation of peripheral intrahepatic
shunts between main hepatic veins), and 7.1% had grade IIIb–IV com-nardi, MD, Carlo
d Piero Buccianti, MD
MbC hepatectomy lowers the need for MH and allows for the
resection of potentially inoperable patients without negative impact on
safety and survival.
(Medicine 94(29):e1188)
Abbreviations: ALPPS = Associating Liver Partition and Portal
vein ligation for staged hepatectomy, CC = hepato-caval
confluence, CRLM = colorectal liver metastases, CT = computed
tomography, DFS = disease-free survival, HV = hepatic vein, IOUS
= intraoperative ultrasound, IRHV = inferior right hepatic vein,
IVC = inferior vena cava, LR = liver resection, MbC = minor-but-
complex, MH = major hepatectomy, MHV = middle hepatic vein,
OS = overall survival, PHLF = posthepatectomy liver failure, PMH
= potentially major hepatectomy, PTFE = polytetrafluoroethylene,
PVE = portal vein embolization, RHV = right hepatic vein.
INTRODUCTION
S urgical resection of colorectal liver metastases (CRLM) isthe only treatment associated with cure or long-term survi-
val in this setting. Unfortunately, only a minority of patients
with liver metastases are suitable for liver resection (LR).
Therefore, strategies to increase the rate of resectable patients
are under active investigation.
A major hepatectomy (MH) is commonly defined as the
resection of 3 or more adjacent hepatic segments. The presence
of a CRLM in contact with the right or middle hepatic vein
(MHV) at the hepato-caval confluence (CC) is usually an
indication to perform a major LR, since all the drained liver
segments are removed. Due to increased rates of perioperative
morbidity and mortality related to MH,1 a lot of strategies were
developed in the last 20 years to increase the future liver
remnant volume: portal vein embolization (PVE),2 portal vein
ligation,3 two-stage hepatectomy,4,5 and more recently the
novel ‘‘ALPPS’’ technique (Associating Liver Partition and
Portal vein ligation for staged hepatectomy).6,7
In 2005 Torzilli et al proposed another approach to reduce
the risk associated with MH introducing the concept of the
‘‘radical but conservative’’ ultrasonography-guided liver
surgery. The basis of this approach is to overcome the limiting
factor of the future liver remnant by transforming an MH in a
minor hepatectomy.8 Torzilli et al for the first time studied the
importance of the liver skeleton and the fundamental role of
communicating veins between adjacent HV identified by theperative ultrasound (IOUS).9 The radical
sophy is a new way to think the liver
ew techniques to spare liver parenchyma
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when HV should be resected at the CC,10–12 as an extension of the
interventions proposed by Makuuchi et al based on the preser-
vation of the inferior right hepatic vein (IRHV).13 All these
procedures, however, are based on the capability to detect and
preserve the communicating veins. This implies a high skill in
performing IOUS and to turn it into a guide to safely resect the
liver parenchyma.
Most liver surgeons are unable to detect intraoperativelly
such small anastomoses and are reluctant to leave congested areas
in the liver remnant. The same problem was encountered in living
donor right liver transplantation where congested areas mean
nonfunctional liver, but preservation of an adequate outflow
allows for the subsequent development of those anastomoses.
Based on this concept, we have introduced the ‘‘minor-but-
complex’’ (MbC) liver resection paradigm as an alternative to
MH. It consists in maintaining the blood flow in the main
intrahepatic vessels in contact with CRLM using surgical skills
maturated in the field of liver transplantation, as a ‘‘bridge’’ to
the peripheral intrahepatic shunts maturation. In this way, the
parenchymal sparing liver surgery is not dependent on the
extremely difficult ultrasound identification and preservation
of the intrahepatic shunts between HV.
The aim of this study is to evaluate whether the MbC
approach could reduce the need for MH for CRLM located in
segments 1, 7, 8, or the cranial portion of segment 4 without
affecting the clinical outcome. Therefore, surgical complexity,
safety, and oncological results of the MbC approach was
compared with those of minor hepatic resections performed
for CRLM far from the CC.
METHODS
Terminology
The terminology for liver anatomy and resections is based
on Brisbane classification.14 Hepatic resections are considered
major when at least 3 adjacent segments are removed. LRs
requiring the exposure of inferior vena cava (IVC), the main
trunks of the HV, or both are considered complex. ‘‘Potentially
major hepatectomy’’ (PMH) is defined before LR when the
preoperative-computed tomography (CT) scan showed a CRLM
in contact with the right HV (RHV) and/or the middle HV
(MHV) at the CC. The hepatectomy was not considered PMH
when the preoperative-CT scan showed an IRHVallowing a safe
RHV resection.13 Patients were defined potentially inoperable
when, at the preoperative-CT scan, the CRLM appeared in
contact with the right and left inflow and/or outflow requiring a
left and a right hepatectomy at the same time, thus precluding
also the treatment with PVE, two-stage resection and ALPPS
without vascular reconstruction. A paradigmatic case of poten-
tially inoperable case is shown in Figure 1.
The ‘‘50–50’’ criteria was used to define posthepatectomy
liver failure (PHLF),15 and clinical severity was classified
according to the grades proposed by the International Study
Group of Liver Surgery.16
Postoperative biliary fistula was defined as bilirubin con-
centration in drain discharge that exceeded 10 mg/dL for at least
3 days, starting from the 5th postoperative day. Ascites was
defined by more than 10 mL/kg/day of drainage output from the
abdomen after the 3rd postoperative day.17 Postoperative com-
plications were stratified according to the Dindo–Clavien
classification.18 Major complications (grade IIIb-IV) and oper-
Urbani et alative mortality (grade V) were considered postoperative when
they occurred within 1 month from surgery or during the
hospital stay even when longer than 1 month.
2 | www.md-journal.comLocal tumor recurrence was defined as the cut-edge recur-
rence (true recurrence). Tumor recurrence in the ‘‘liver saved by
MbC’’ was the recurrence in the liver parenchyma that would
have been resected in the case of MH.
Eligibility Criteria
Among all consecutive patients who underwent LR in our
Center from December 2008 until December 2013, those who
had CRLM involving segments 1, 7, 8, or the cranial portion of
segment 4 were included in this study (Figure 2). In particular,
all patients potentially requiring an MH, independently from the
previous treatment received, were enrolled. Only those patients
undergoing a two-stage approach were excluded. This is a
retrospective study conducted in accordance with the Declara-
tion of Helsinki. All patients included provided written
informed consent before treatment initiation, allowing phys-
icians to administer the proposed treatment, perform the appro-
priate surgical intervention, and collect all the data in a site-
specific database. None of the authors declare potential conflict
of interest.




According to the surgical procedure applied, the patients
be divided in three groups:could
(1) the MINOR resection group: removal of less than 3
adjacent segments without the need of IVC exposure and/
or the main trunks of the HV;(2) the MbC resection group: removal of less than 3 adjacent
segments but with the need of IVC exposure and/or the
main trunks of the HV; and
(3) the MAJOR resection group: removal of 3 or more
adjacent segments.
Preoperative Work-Up
Preoperative imaging work-up consisted in abdominal
ultrasound, total-body CT, and magnetic resonance imaging.
Patients were selected for surgery after a multidisciplinary
board also involving medical oncologists and radiologists.
The technical feasibility was established when residual liver
volume with preserved blood inflow and outflow, and biliary
drainage was expected to be more than 30% of the total
functional liver volume. Liver volumes were calculated based
on CT images.
Operative Technique
A J-shaped laparotomy was usually performed. For those
patients with tumor close to the CC a J-shaped thoracophreno-
laparotomy was eventually carried out.19 For those patients with
associated lesions of other organs the xipho-pubic incision was
preferred. Laparoscopic approach was considered for small
single lesions.
The IOUS was performed using a BK Medical – ProFocus
Ultraview1.
Surgical strategy was based on IOUS findings regarding
CRLM relationships with intrahepatic vascular structures.
When the CRLM is in contact with the HV without any sign
of wall discontinuation the attempt to dissect the vessel from the
CRLM was always performed (Figure 3). If the vessel was
resected the HV was always reconstructed by direct suture, or
by anastomosis (Figure 4), or by the interposition of a ringedetrafluoroethylene (PTFE) 7 mm graft (Atrium Medical
oration, NH) (Figure 1), except for the RHV in presence of
.13
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FIGURE 1. A case of minor-but-complex hepatic resection with hepatic vein reconstruction with ringed PTFE graft used as ‘‘a bridge’’ to
intrahepatic shunt maturation. This patient had 6 synchronous colorectal metastasis (CRLM) and after the resection of primary tumor had
good response to 8 cycles of FOLFOXIRI plus Bevacizumab. (A) This case was judged potentially inoperable on the basis of preoperative CT
scan. Liver outflow was infiltrated by different CRLM at the hepato-caval confluence (CC) involving the left hepatic vein (HV) for segments
2 and 3 (V2, V3) and middle HV (MHV), and far from the CC involving the right HV (RHV). Liver inflow was also involved by CRLM
interesting right portal branch for segment VIII (P8) and the CRLM infiltrating RHV close to the posterior right portal branch (P6–7). (B) The
intraoperative field of the resection of segment VIII–IVa partially extended to segment VII and II and to the paracaval portion of segment I
with the exposure of all the main intrahepatic vascular structures at the CC. Left hepatic outflow was reconstructed with 3 ringed PTFE
grafts: V2 was reconstructed directly on the cava vein, V3 was reconstructed on the RHV where it was tangentially resected for the adjacent
CRLM, the MHV was reconstructed at the level of the confluence of the hepatic vein of segment VII with the RHV. Right inflow was
preserved with the complete exposure of P6–7 and with the section of P8 at his origin. The resected liver presented no sign of congestion
with all the residual segments well perfused. The liver cut surface was 241 cm2, the cumulative clamping time was 292 minutes, 8 units of
red packed cells were requested (preoperative anemia 8,6 Hb and metabolic acidosis due to chemotherapy), the postoperative course was
characterized by transient ascites, and the patient was discharged on the 14th postoperative day; successively, a delayed biloma was
treated with a percutaneous drainage. Eight months after liver surgery the patient is alive and well without any sign of disease recurrences.
(C) The CT scan on the 11th postoperative day shows a well perfused left liver in spite of the thrombosis of the V2 PTFE graft (due to
presence of intrahepatic shunts between V2 and V3). There were no-evident shunts between V3 to MHV and MHV to RHV. Red arrows
indicate a laminar thrombus in both MHV and V3 PTFE. (D) The CT scan 5 months after shows the resolution of the thrombus in the MHV
PTFE graft (blue arrow) and the complete thrombosis of the V3 PTFE graft (red arrow) with a well perfused left liver because of the
HV;
Medicine  Volume 94, Number 29, July 2015 Minor-But-Complex Liver ResectionSince we have considered all the consecutive LRs per-
formed from the beginning of our LR program, some technical
aspects changed overtime to realize the MbC hepatectomy. The
main changes are briefly reported in the following points.
The liver dissection at the beginning was performed by the
crush-clamp technique or the ultrasonic dissector with the effort
spontaneous maturation of peripheral shunts between V3 and Mof the anesthesiologist to keep central venous pressure at less
than 5 mmHg; hemostasis and biliostasis were achieved with
extensive use of coagulation devices and the use of titanium
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.clips to secure vessels >2 mm in thickness; and pedicle clamp-
ing was performed only in case of bleeding. With the increasing
complexity of the resections, the titanium clips were abandoned
and vessels >2 mm in thickness were ligated with thin (3/0)
reabsorbable sutures (Vicryl1, Ethicon), bipolar electro cau-
tery coagulation was used for <2 mm vessels only. Titanium
peripheral shunts are also maturating around RHV.clips and other coagulation devices were used only in laparo-
scopic liver surgery. Once liver transection was concluded, the
liver cut surface was routinely monitored for about 50 minutes,
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FIGURE 2. Flow-chart of all the liver resections performed from
December 2008 until December 2013 with the selection of the
study population. CRLM¼ colorectal liver metastasis; LR¼ liver
Urbani et aland any bleeding or bile leakage points were controlled by thin
reabsorbable sutures and bipolar forceps.
At the beginning of our LR experience, we preoperatively
planned to treat single <1 cm CRLM by intraoperative thermo-
ablation with the aim to spare liver parenchyma, but with the
improvement of the surgical skill intraoperative thermoablation
was no more used.
Another stepwise change in our study cohort regards the
performing of liver dissection under intermittent pedicle clamp-
ing. At the beginning the Pringle manoeuvre was carried out for
15 minutes followed by 5 minutes of reperfusion. Then we
prolonged the reperfusion time for 10 minutes. With the
increasing complexity of the cases, especially for vascular
reconstructions, longer clamping durations became inevitable,
thus we adopted a reperfusion time equal to the clamping time.
Outcome Measures
The primary objective of this study was to assess the rate of
patients with liver CLRM candidate to MH who may benefit by
the MbC resection approach. This was obtained by the differ-
ence between the rate of PMH plus potentially inoperable cases
and the effective rate of the MH performed.
The secondary endpoint was to evaluate safety, complexity,
and oncological results of the MbC approach. Taking into account
that postoperative mortality is mainly related to the amount of
resected liver1 and due to the limited number of patients in the
MAJOR group, we focused on comparing these categories
between patients treated with MINOR and MbC resections,
who had comparable residual liver volume. For safety, we
analyzed: rate of 0 mm margin resections, need of blood transfu-
sion, hospital stay, rate of biliary leak, rate of postoperative
ascites, rate of postoperative liver failure, and liver related deaths,
need for continuous veno-venous hemofiltration (CVVH), mor-
bidity and 90-day mortality using the Dindo–Clavien classifi-
resection; PMH¼potentially major hepatectomy; IRHV¼ inferior
right hepatic vein.cation.18 For complexity, we analyzed: rate of previous liver
treatment other then systemic chemotherapy, number of PMH,
number of potentially inoperable cases, type of incision, duration
4 | www.md-journal.comof surgery, inflow clamping time, need of vascular reconstruction
(and type of vascular reconstruction), occurrence of reconstructed
vessels thrombosis, liver cut surface, and associated surgical
procedures. For oncological results: rate of recurrence, site of
recurrence, intrahepatic recurrence with rate of true local recur-
rence, and of recurrence in the ‘‘liver saved by the MbC
approach’’; overall survival (OS) and progression-free survival;
rate of redo-surgery and rate of disease-free patients after the
redo-surgery at the cut-off date.
Patient Follow-up
After surgery, follow-up routine visits were scheduled
every 2 months with physical examination, complete blood
profile, CEA, and CT scan of the chest and abdomen (every
2 months for the 1st year, every 4 months for the 2nd and the 3rd
year, and every 6 months thereafter). The cut-off date for
analyses was June 1, 2014.
Statistical Analysis
This is a retrospective cohort study. Continuous variables
were compared using t-test, categorical variables were ana-
lyzed by Fisher exact test and Chi square test. Disease-free
survival (DFS) and OS were determined using the Kaplan–
Meier method and compared according to type of surgery
using the log-rank test. Statistical significance was set at P <
0.05 for a two-tailed test. Statistical analyses were carried out




The General Surgery Unit of the Azienda Ospedaliero-
Universitaria Pisana performs an average of 300 surgical pro-
cedures per year for the treatment of primitive colorectal
neoplasms. The Liver Resection Program started in December
2008 when an experienced liver transplant surgeon20,21 entered
in the colorectal surgical team with the aim to offer a complete
surgical treatment opportunity for patients affected by color-
ectal malignancies.
From December 16, 2008 to December 31, 2013, 126 LRs
were performed. Based on the aforementioned inclusion
criteria, 62 consecutive LRs were included in this study. Three
Medicine  Volume 94, Number 29, July 2015casesPMH
impl
perfo
Cowere excluded because they were the first stage of a
rammed two-stage LR. The 59 consecutive LRs analyzedprog
(Figure 2) were divided in 3 groups as follows:
MINOR: 23 (39.0%) LRs, in 1 (4.3%) case a <1 cm(1)
CRLM was intraoperative thermo ablated;
MbC: 28 (47.5%) LRs, in 2 (7.1%) cases a <1 cm CRLM(2)
was intraoperative thermo ablated; and
(3) MAJOR: 8 (13.5%) LRs, in 2 (25%) cases a<1 cm CRLM
was intraoperative thermo ablated.
Table 1 reports patients’ characteristics and oncological
features of primary tumor and liver metastases. In the 32.1% of
the MbC cases, the liver already received a previous treatment
other than systemic chemotherapy, and in 20% it was a
surgical treatment.
At preoperative evaluation, 33 (55.9%) cases were deemed
(29, 49.1%) or potentially inoperable (4, 6.8%). Due to the
ementation of the MbC approach the final number of MH
rmed was 8 (13.5%). The decrease of MH for CRLM
pyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
FIGURE 3. A case of minor-but-complex hepatic resection with hepatic vein preservation. This patient after 10 cycles of FOLFIRI and
cetuximab was judged not operable with a major hepatectomy due to severe steatosis; therefore, she was treated with loco-regional
treatment (transarterial chemoembolization). (A) Preoperative-CT scan shows the colorectal metastasis (CRLM) at the hepato-caval
confluence (CC) under the plane of the hepatic veins and close to all the main vascular structures of the liver: right hepatic vein (RHV),
middle hepatic vein (MHV), left portal branch (P left), anterior portal branch (P8), and cava vein. (B) This is the intraoperative field of the
bisegmentectomy (I–IV) partially extended to the ventral part of segment VIII, with the exposure of all the main intrahepatic vascular
structures; the intraoperative ultrasound excluded the infiltration of all the vascular structures in particular there was no vessel wall
discontinuation for the MHV; the histological analysis showed 0 mm margins close to the main hepatic vessels, the liver cut surface was
212 cm2, the cumulative clamping time was 304 minutes, no blood transfusion was requested, the postoperative course was complicated
by a transient elevation of creatinine, and the patient was discharged on the 17th postoperative day. (C) CT scan 18 months after liver
ym
Medicine  Volume 94, Number 29, July 2015 Minor-But-Complex Liver Resectionlocated in segments 1, 7, 8, and the cranial portion of segment 4
was 42.4%.
Secondary Outcome
The 90-day mortality was nil in the MbC resection group.
Overall, only 2 (5.1%) patients died in the perioperative course:
one because of myocardial infarction on the 9th postoperative
day after a minor resection associated to rectal anterior resec-
tion, and another on the 32nd postoperative day due to septic
hepatic artery bleeding after an MH associated to biliary
reconstruction and retrohepatic caval resection.
We report in details in Tables 2–4 the differences in safety,
surgery shows a normal right and left liver consistent with a parench
disease recurrence.complexity, and oncological outcomes between MINOR versus
MbC and MbC versus MAJOR hepatectomies. Taking into
account that postoperative mortality is mainly related to
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.the amount of resected liver1 and given the small number of
patients in the MAJOR group (8 cases), we here report the
comparison of the secondary outcome measures between
MINOR and MbC-resection groups, which had comparable
residual liver volume.
Regarding safety (Table 2), 1 case (3.6%) of severe but not
fatal PHLF was observed in the MbC group. This patient was 1
of the 2 cases with severe hypotension during MbC resection
associated with postoperative multiorgan dysfunction and sep-
sis by KPC-producing Klebsiella pneumoniae. One of them was
reoperated twice because of hemoperitoneum and both the
patients needed CVVH. During the follow-up all the livers
al sparing surgery; the patient is alive and well without any sign ofwere well perfused, PTFE graft thrombosis occurred in 2 out of
3 grafts, but only when intrahepatic shunts between main HV
were present (Figure 1).
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had a second hepatic or extrahepatic surgery, which increased
FIGURE 4. A case of minor-but-complex resection with hepatic vein anastomosis. This patient was judged not operable in another Center
and was treated with loco-regional treatment (transarterial radio-embolization with yttrium). Due to a severe aortic valve stenosis 3 days
before liver surgery, the patient was treated with percutaneous aortic valvuloplasty with reduction of gradient from 75 to 35 mmHg and
started antiaggregant therapy. (A) Preoperative CT scan shows the colorectal metastasis (CRLM) at the hepato-caval confluence (CC) in
contact with right hepatic vein (RHV) and apparently infiltrating the middle hepatic vein (MHV). (B) This is the intraoperative field of this
minor-but-complex resection of segment 4a partially extended to segment VIII and to the paracaval portion of segment I, and with the
exposure of all the main intrahepatic vascular structures at the CC: retrohepatic cava vein, left hepatic vein (LHV), and the termino-lateral
anastomosis of the MHV with the RHV; the intraoperative ultrasound showed no MHV wall discontinuation, and the histological analysis
confirmed the absence of MHV infiltration by the CRLM, the liver cut surface was 155 cm2, the cumulative clamping time was 185 minutes,
no blood transfusion was requested, the postoperative course was uneventful, and the patient was discharged on the 6th postoperative
day; 8 months after liver surgery, the patient presented a liver and lymph nodes recurrence; at the end of follow-up he is alive and well with
tera
s be
Urbani et al Medicine  Volume 94, Number 29, July 2015Table 3 describes the results for complexity. In the MbC
group 2 patients had the resection of more than 3 segments, but
there were no 3 adjacent segments resected. In the MbC group,
the 89.3% of LRs were PMH or potentially not operable. In the
MbC group, there was a significant higher use (P¼ 0.02) of the
thoraco-abdominal approach (21.4%).
In the 28 MbC resections, the parenchyma was spared
using different approaches: in 11 (39.1%) cases using a vascular
reconstruction, in 2 (7.1%) cases resecting the RHV at the CC in
presence of an IRHV, and in 15 (53.6%) cases by the complete
exposure of the HV (as shown in Figure 3). In these cases
median operative time (800 minutes, P< 0.01), median Pringle
time (217 minutes; P< 0.01), and median liver cut surface
(196 cm2; P¼ 0.01) were significantly higher than the MINOR
resection group, where there was a significant higher incidence
(P¼ 0.01) of associated surgical procedures (56.5%).
Table 4 summarizes the oncological results. The median
follow-up in the groups of MINOR and MbC resections was
disease recurrences. (C) A particular of the CC with the termino-la
months after liver resection shows the patency of the anastomosi22.2 (0.3–62.7) months with no significant difference between
them. Patients in the MbC group were more complex also from
the oncological point of view. The median number of 3 CRLM
6 | www.md-journal.comand the median size of the largest CRLM (3.9 cm) were
significantly higher than in the MINOR group (P¼ 0.04 and
P< 0.01). As a consequence, more patients (75%) received
preoperative chemotherapy with a median number of 6 cycles
(P< 0.01).
There was no significant difference between MINOR and
MbC groups in DFS (41.2% versus 29.2%, P¼ 0.89) and OS
(85.5% versus 85.8%, P¼ 0.54). There was a statistically
significant difference in OS between MbC and MAJOR hepa-
tectomies (85.8% versus 50.0%, P¼ 0.02), but not in the DFS
(29.2% versus 25.0%, P¼ 0.67). One third of the MbC patients
l anastomosis between the MHV and the RHV. (D) The CT scan 4
tween MHV and RHV.the DFS at the cut-off date from 35.7% (after the first LR) to
53.6%.
DISCUSSION
In the recent years, the availability of more pharmacologi-cal options and the evolution of the interventional techniques
increased complexity of metastatic colorectal cancer treatment.
In order to maximize patient’s survival, a multidisciplinary
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 1. Baseline Patients’ Characteristics
All Minor Minor-but-Complex Major
(n¼ 59) (n¼ 23) (n¼ 28) (n¼ 8)
Median, range age, y 66 (33–83) 68 (41–77) 66 (37–82) 64 (33–83)
M:F 39:20 13:10 21:7 5:3
ECOG
0 45 (76.3) 19 (82.6) 20 (71.4) 6 (75)
1 14 (23.7) 4 (17.4) 8 (28.6) 2 (25)
Site of primary
Right colon 14 (23.7) 6 (26.1) 7 (25) 1 (12.5)
Left colon 25 (42.4) 5 (21.7) 17 (60.7) 3 (37.5)
Rectum 20 (33.9) 12 (52.2) 4 (14.3) 4 (50)
Stage of primary
II 22 (37.3) 15 (65.2) 4 (14.3) 3 (37.5)
III 37 (62.7) 8 (34.8) 24 (85.7) 5 (62.5)
Unresected primary
Yes 15 (25.4) 8 (34.8) 3 (10.7) 4 (50)
No 44 (74.6) 15 (65.2) 25 (89.3) 4 (50)
Prior adjuvant chemotherapy
Yes 24 (40.6) 12 (52.2) 11 (39.3) 1 (12.5)
No 35 (59.4) 11 (47.8) 17 (60.7) 7 (87.5)
KRAS status
Wild-type 29 (49.9) 13 (56.5) 11 (39.3) 5 (62.5)
Mutated 30 (50.1) 10 (43.5) 17 (60.7) 3 (37.5)
BRAF status
Wild-type 59 (100) 23 (100) 28 (100) 8 (100)
Mutated 0 0 0 0
Liver metastases
Synchronous 37 (62.7) 15 (65.2) 16 (57.1) 6 (75.0)
Metachronous 22 (37.3) 8 (34.8) 12 (42.9) 2 (25.0)
Number of CRLM, median (range) 2 (1–12) 1 (1–12) 3 (1–11) 2 (1–10)
Size (cm) of largest CRLM, median (range) 3.0 (1.0–10.0) 2.0 (1.0–4.5) 3.9 (1.6–10.0) 4.4 (2.0–5.8)
Bilateral disease, no., % 16 (27.1) 1 (4.3) 12 (42.9) 3 (37.5)
Previous liver treatment, no., % 13 (22.0) 4 (17.4) 9 (32.1) 0
TACE 1 0 1
TARE (Yttrium) 1 0 1
Radiotherapy 1 1 0
Radiofrequency 1 0 1
Liver resection 9 3 6
Preoperative chemotherapy, no., %
Yes 34 (57.6) 8 (34.8) 21 (75) 5 (62.5)
No 25 (42.4) 15 (65.2) 7 (25) 3 (37.5)
Mono 2 (3.4) 0 (0) 1 (3.6) 1 (12.5)
Doublet 22 (37.3) 6 (26.1) 14 (50) 2 (25.0)
Triplet 10 (16.9) 2 (8.7) 6 (22.2) 2 (25.0)
Biological, no., % 30 (50.8) 6 (26.1) 19 (67.8) 5 (62.5)
No. of Cycles, median (range) 6 (0–13) 0 (0–11) 6 (0–12) 12 (9–13)
CRLM¼ colorectal liver metastasis, ECOG¼ eastern cooperative oncology group performance status, TACE¼ transarterial chemoemolization,
Medicine  Volume 94, Number 29, July 2015 Minor-But-Complex Liver Resectionmanagement is mandatory, and the surgical approach should
balance the achievement of the radical aim with the possibility
of reoperation and the need to perform pre- and postoperative
systemic treatments. In this context, we reported our experience
with MbC resections that allowed for resecting patients other-
wise inoperable or candidate to MH, which is associated with
TARE¼ transarterial radioembolization.high mortality and major morbidity. In this retrospective study,
we showed that the safety profile of MbC resections is com-
parable to that of minor resections, in spite of the higher degree
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.of complexity due to the spread of the tumor and to the prior
treatments applied. Nevertheless, this novel operative technique
involved multiple combined procedures (including the surgical
management of intrahepatic vessels) prolonging the operative
times as well as the clamping times. However, it has already
been shown22,23 that long operations were associated with those
series featuring the best results in terms of safety. Indeed, in our
MbC resections, the median hospital stay was 9 days (7 days in
patients with MINOR resections) and the rate of major
www.md-journal.com | 7
TABLE 2. Safety of the Minor-but-Complex hepatectomy
All Resections Minor Minor-but-Complex Major P Value P Value
(n¼ 59) (n¼ 23) (n¼ 28) (n¼ 8) Minor vs MbC MH vs MbC
0 mm margins, no., % 13 (22.0) 4 (17.4) 8 (28.6) 1 (12.5) 0.50 0.65
Hospital stay (days), median (range) 8 (3–159) 7 (3–13) 9 (4–159) 10 (6–31) 0.12 0.75
90-day mortality, no., % 2 (3.4) 1 (4.3) 0 (0) 1 (12.5) 0.45 0.22
LR with complications, no. , % 25 (42.4) 6 (26) 15 (53.6) 4 (50.0) 0.08 1.00
LR with grades I–II, no., % 14 (23.7) 4 (16) 9 (32.1) 1 (12.5) 0.33 0.40
LR with grades IIIb–IV, no. , % 4 (6.8) 0 (0) 2 (7.1) 1 (12.5) 0.4949 0.54
LR with grade V, no., % 2 (3.4) 1 (4.3) 0 (0) 1 (12.5) 0.45 0.22
Need for blood transfusion, no., % 16 (27.1) 3 (13.0) 11 (39.3) 2 (25.0) 0.06 0.68
Emoperitoneum, no., % 3 (5.1) 0 (0) 2 (7.1) 1 (12.5) 0.49 0.54
Biliary leak, no., % 1 (1.7) 0 (0) 1 (3.6) 0 (0) 1.00 1.00
Pleural effusion, no., % 10 (16.9) 1 (4.3) 7 (25.0) 2 (25.0) 0.06 1.00
Ascites, no., % 2 (3.4) 0 (0) 1 (3.6) 1 (12.5) 1.00 0.40
Need for CVVH, no., % 3 (5.1) 0 (0) 2 (7.1) 1 (12.5) 0.49 0.54
Liver failure, no., % 1 (1.7) 0 (0) 1 (3.6) 0 (0) 1.00 1.00
Mortality due to liver failure, no., % 0 (0) 0 (0) 0 (0) 0 (0) 1.00 na
Mb
Urbani et al Medicine  Volume 94, Number 29, July 2015complications (7.1%) was not higher than the 17% to 26%
reported in other series of noncirrhotic patients.23,24 Among the
factors that may explain these favorable results and the surpris-
ingly 0% perioperative mortality, there is the large amount of
residual parenchymal volume left after the resections.1
In the last 2 decades, other multistep approaches (ie, PVE,
two-stage resection) attempted to increase the liver mass left
after resections. Nevertheless, 15% of the patients did not
benefit from PVE, mainly because of disease progression or
insufficient remnant liver hypertrophy,25 thus up to 33% of
patients did not complete the two-stage strategy.26 Although the
interval between the 2 steps may help to identify patients with
better prognosis by revealing tumor biology behavior,26 it is not
clear yet whether tumor progression could be favored by the
growth stimuli of the induced liver cell hyperplasia.6 The recent
introduction of the ALPPS technique allows for a significant
contraction of interval between the 2 steps, but the potential
oncological effect of the massive regeneration remains an open
issue.7
Similarly to what reported with the radical but conserva-
tive parenchymal-sparing surgery,27,28 the MbC approach pro-
vided instead the opportunity to treat in a single-step procedure
complex cases with 0% mortality at 90 days. This is remarkable
when compared with the high perioperative mortality of MH. In
our study cohort, only 8 patients underwent MH and 1 died
(12.5%), which is in line with the 10.3% perioperative mortality
reported by Cauchy et al,29 when MH was performed in initially
unresectable patients. Noteworthy, in these complex cases
Brouquet et al26 reported a high postoperative mortality (2%
and 6% at 30 and 90 days) also for the two-stage approach, as
well as Schnitzbauer et al6 reported a 44% grade III and IV
complications with 12% hospital lethality in the first
ALPPS series.
Overall, in our cohort of 59 consecutive patients with
CRLM localized in segments 7, 8, 4a, and 1, the development
of the MbC resection approach lowered by 42.4% the need for
CVVH¼ continuous veno-venous hemofiltration, LR¼ liver resection,MH and opened the way to a new extensive parenchymal
sparing liver surgery. To perform such a complex surgery
the liver dissection technique changed stepwise, abandoning
8 | www.md-journal.comthe coagulation devices to better preserve the liver skeleton. A
major effort was requested to the anesthesiology team who
developed a specific expertise in avoiding hypotension during
the very long intermittent clamping times. In fact, at the
beginning of our series, the extensive use of pedicle clamping
was associated with intraoperative hypotension and followed by
multiorgan failure in 2 patients, including severe liver failure in
1 case. In our initial experience, we also reported the 367
minutes longest cumulative clamping time that, however,
was not associated to an unfavorable outcome.30 Indeed, none
of the patients died after an MbC resection in spite of the
complexity of the surgery, who is underlined by the extension of
the liver cut surface, by the 32.1% of previous treatments other
than systemic chemotherapy, and by the 39.3% of LRs with
vascular reconstruction.
Vascular reconstructions were reported to increase the
mortality risk when are associated to MH,29,31 but this obser-
vation is not confirmed by all the authors.32,33 In the MbC
setting, surgical management of hepatic vascular structures did
not represent an additional risk factor for postoperative liver
failure. We may explain this result taking into account that the
HV reconstruction in our approach is not done on the single HV
left, but it is set to work as ‘‘a bridge’’ until intrahepatic shunts
maturation. The residual liver perfusion obtained with our
approach is optimal and comparable to that obtained by Torzilli
et al,8 which requires real-time hemodynamic IOUS study to
identify the liver skeleton and a special skill to transform the bi-
dimensional view of the IOUS in the 3-dimensionality of the
liver cut surface. Thus, our technique may overcome an obstacle
to a wider diffusion among surgeons of the parenchymal sparing
concepts introduced by Torzilli et al. The MbC approach is
aimed to maintain the ‘‘vertical’’ blood flow in main HV as ‘‘a
bridge’’ to spontaneous maturation of ‘‘horizontal’’ blood flow
in peripheral intrahepatic shunts. The article by Hwang et al34
reinforced our concept of ‘‘the bridge’’ solution. In fact, the
authors, describing the role of ringed PTFE grafts for the
C¼minor-but-complex, MH¼major hepatectomy, na¼ not applicable.reconstruction of MHV in living donor right liver transplan-
tation, documented that the progressive obliteration of the PTFE
graft does not affect the liver graft perfusion and survival. A
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.
















Potentially major hepatectomy, no., % 29 (49.1) 0 22 (78.6) 7 (87.5) <0.01 1.00
Potentially Inoperable, no., % 4 (6.8) 0 3 (10.7) 1 (12.5) 0.24 1.00
Incisions, no., %
Xipho-pubic 12 (20.3) 7 (30.4) 2 (7.1) 3 (37.5) 0.06 0.06
J-shape subcostal 35 (64.4) 15 (65.2) 20 (71.4) 3 (37.5) 0.76 0.11
Thoracophrenolaparotomy 8 (13.6) 0 (0) 6 (21.4) 2 (25.0) 0.02 1.00
Laparoscopic 1 (1.7) 1 (4.3) 0 (0) 0 (0) 0.45 na
Segments resected, no., %
<1 16 (27.1) 14 (60.8) 2 (7.1) –
1–2 24 (40.7) 9 (39.2) 15 (53.6) –
2–3 9 (15.2) 9(32.1) –
3–4 5 (8.5) 1 (3.6)

4 (50.0)
4–5 2 (3.4) – 2 (25.0)
5–6 3 (5.1) 1 (3.6)y 2 (25.0)z
LR with associated surgical procedures, no., % 23 (39.0) 13 (56.5) 6 (21.4) 4 (50.0) 0.01 0.18
Right emicolectomy 2 1 1 0
Left emicolectomy 2 0 2 0
RAR 9 7 0 2
Ileostomy 9 7 0 2
Ileostomy closure 4 2 2 0
Diaphragmatic resection 1 0 1 0
Left adrenalectomy 2 2 0 0
Hepatico-jejunosthomy 1 0 0 1
Infrarenal aortic lymphadenectomy 1 0 0 1
Hysteroannessiectomy 2 1 0 1
LR with vascular reconstructions, no., % 13 (22.0) 0 (0) 11 (39.3) 2 (25.0) <0.01 0.44
RHV tangential 5 0 4 1
RHV termino-terminal 1 0 1 0
MHV tangential 3 0 3 0
MHV termino-lateral on RHV 1 0 1 0







Cava tangential 3 0 2 1
Operative time (min), median (range) 520 (180–1240) 420 (180–670) 800 (320–1240) 652 (320–1110) <0.01 0.69
Pringle (min), median (range) 100 (0–367) 60 (0–176) 217 (0–367) 97 (0–175) <0.01 0.23
Liver cut surface (cm2), median (range) 134 (48–288) 90 (48–187) 196 (55–288) 95 (80–185) 0.01 0.12
LR¼ liver resection, MbC¼minor-but-complex, MH¼major hepatectomy, MHV¼middle hepatic vein, na¼ not applicable,
PTFE¼ polytetrafluoroethylene graft, RAR¼ rectal anterior resection, RHV¼ right hepatic vein, V2¼ hepatic vein of segment II, V3¼ hepatic
vein of segment III. @ Graft thrombosis with normal liver perfusion due to the presence of intrahepatic shunts between hepatic veins (see Figure 1).
There was no resection of 3 adjacent segments.
yThere was no resection of 3 adjacent segments: bisegmentectomy of VI–VII, segmentectomy of segment I extended to segment VIII ventral and
bisegmentectomy of II–III.
zOne patient received preoperative PVE and was treated with a right hepatectomy extended to segment I and IVa, the other liver resection consisted
in a left hepatectomy extended to segment I associated to segmentectomy of segment VII.
Medicine  Volume 94, Number 29, July 2015 Minor-But-Complex Liver Resectionrecent study by Hribernik and Trotovšek35 demonstrated the
existence of peripheral intrahepatic venous anastomoses of
1 mm of diameter or less in the corrosion casts obtained from
macroscopically normal cadaveric livers. These thin commu-
nicating veins are undetectable in condition of normal blood
flow, even with new-generation CT, or magnetic resonance
imaging.9 The case described in Figure 1 is highly explicative of
the MbC approach. In this potentially inoperable patient, the left
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.outflow was completely reconstructed using 3 ringed PTFE
grafts. The CT scan at 5 months from LR shows the maturation
of the shunts between V3 (hepatic vein for segment 3) and
MHV, which were not evident on the CT scan at postoperative
day 11. For this reason the left liver remained well perfused in
spite of the thrombosis in 2 PTFE grafts.
The other methods used to maintain the blood flow in main
HV at the CC alternative to perform an MH are the preservation
www.md-journal.com | 9
TABLE 4. Patients’ Characteristics and Oncological Results of the Minor-but-Complex Hepatectomy, Significant Values Are Presented in Bold
All Resections Minor Minor-but-Complex Major P Value P Value
(n¼ 59) (n¼ 23) (n¼ 28) (n¼ 8) Minor vs MbC MbC vs MH
Median, range age, years 66 (33–83) 68 (41–77) 66 (37–82) 64 (33–83) 0.44 0.33
M:F 39:20 13:10 21:7 5:3 0.23 0.66
Liver metastases
Synchronous, % 37 (62.7) 15 (65.2) 16 (57.1) 6 (75.0) 0.58
Metachronous, % 22 (37.3) 8 (34.8) 12 (42.9) 2 (25.0) 0.66
Number of CRLM, median (range) 2 (1–12) 1 (1–12) 3 (1–11) 2 (1–10) 0.04 0.92
Size (cm) of largest CRLM, median (range) 3.0 (1.0–10.0) 2.0 (1.0–4.5) 3.9 (1.6–10.0) 4.4 (2.0–5.8) <0.01 0.57
Bilateral disease, no., % 16 (27.1) 1 (4.3) 12 (42.9) 3 (37.5) <0.01 1.00
Preoperative chemotherapy, no., %
Yes 34 (57.6) 8 (34.8) 21 (75) 5 (62.5) <0.01
No 25 (42.4) 15 (65.2) 7 (25) 3 (37.5) 0.66
Mono 2 (3.4) 0 (0) 1 (3.6) 1 (12.5)
Doublet 22 (37.3) 6 (26.1) 14 (50) 2 (25.0)
Triplet 10 (16.9) 2 (8.7) 6 (22.2) 2 (25.0)
Biological, no., % 30 (50.8) 6 (26.1) 19 (67.8) 5 (62.5) <0.01 1.00
No. of cycles, median (range) 6 (0–13) 0 (0–11) 6 (0–12) 12 (9–13) <0.01 0.04
Months of follow-up, median (range) 25.2 (0.3–62.7) 31.2 (0.3–62.7) 21.9 (7.4–30.3) 38.2 (1.1–57.5) 0.20 0.03
2-years disease-free survival rate 34.0 41.2 29.2 25.0 0.89 0.67
2-years overall survival rate 80.0 85.5 85.8 50.0 0.54 0.02
Disease free after initial LR at cut-off date 18 (30.5) 7 (30.4) 10 (35.7) 1 (12.5) 0.77 0.39
Site of progression
Lung 15 (25.4) 7 (30.4) 7 (25) 1 (12.5) 0.75 0.65
Bone 3 (5.1) 1 (4.3) 0 (0) 0 (0) 0.45 na
Lymph nodes 7 (11.9) 1 (4.3) 5 (17.8) 1 (12.5) 0.20 1.00
Peritoneum 2 (3.4) 0 (0) 0 (0) 2 (25.0) 1.00 0.04
Ovaries 2 (3.4) 1 (4.3) 1 (3.6) 0 (0) 1.00 1.00
Liver 29 (49.1) 12 (52.2) 12 (42.8) 5 (62.5) 0.57 0.43
Liver saved by MbC – – 2 (7.1) – na na
Location of intrahepatic recurrence
Surgical margins 4 (6.8) 2 (8.7) 1 (3.6) 1 (12.5) 0.58 0.40
Elsewhere 13 (22.0) 8 (34.8) 3 (10.7) 2 (25.0) 0.04 0.30
Both 12 (20.3) 2 (8.7) 8 (28.6) 2 (25.0) 0.09 1.00
Re-do surgery
Hepatic 10 (16.9) 6 (26.1) 4 (14.3) 0 (0) 0.31 0.55
Extrahepatic 7 (11.9) 3 (13) 4 (14.3) 0 (0) 1.00 0.55
Disease free after re-do surgery at cut-off date 27 (45.8) 12 (52.2) 15 (53.6) – 1.00 na


















































































of the HV with 0 mm margin (as described in Figure 3), the
tangential resection and direct suture of the HV, or the direct
anastomoses between main HV (Figure 4).
In conclusion, MbC LRs represent a new way to pursue a
parenchymal sparing policy in liver surgery. Liver transplan-
tation surgical techniques may be used to transform an MH in a
minor hepatectomy respecting the liver skeleton, which allows
for the spontaneous maturation of intrahepatic shunts between
main HV. MbC hepatectomies are more demanding than stan-
dard resections, but more affordable without special IOUS
expertise because vessels reconstructions avoid the complexity
of ultrasound identification and preservation of intrahepatic
shunts.
Overall, the MbC approach allowed treatment of poten-
tially inoperable cases and reduced the need for MHs without
negative impact on safety and oncological outcomes. Despite a
more advanced disease at presentation and a different thera-
peutic algorithm, MbC patients achieved a good oncologic
outcome comparable with patients treated with a MINOR LR.
These results support further efforts in the multidisciplinary
management of patients affected by metastatic colorectal
cancer.
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